The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)

NCT00118508 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: risedronate (including placebo)

Sponsor

University of Pittsburgh

Collaborators

[object Object]
[object Object]